Condition: HIV Infection · Acquired Immune Deficiency Syndrome · Oral Health Care · Sponsor: Nantes University Hospital
Dental care for people living with HIV has evolved with the widespread use of antiretroviral therapy, which has improved life expectancy and disease control. However, uncertainty remains about whether specific adaptations are still needed during dental procedures due to potential biological abnormalities that may increase infectious or bleeding risks. This study aims to evaluate the proportion of patients living with HIV in the Pays de la Loire region who may require adapted dental management based on biological parameters such as immune status, hematological values, and comorbidities. A retrospective descriptive study will be conducted using anonymized data from 5,603 patients followed in the COREVIH Pays de la Loire database. The results are expected to provide objective data to better inform dental practice and reduce unnecessary precautions or stigmatization in the management of patients living with HIV.
This description comes directly from the study's public registry record.
Gilles Amador del Valle, MD, PhD · +33 2 40 08 31 73 · gilles.amadordelvalle@univ-nantes.fr
Alexandra Poinas, PhD · +33 2 53 48 28 57 · alexandra.poinas@chu-nantes.fr
Always discuss trial participation with your own doctor first.
| CHU Nantes-Department of Dentistry | Nantes, Nantes, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07552038